At a glance
The May 17, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on antigen testing, biosafety, SARS-CoV-2 variants, and laboratory supplies, as well as updates from FDA.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
Antigen Testing Guidance: Muktha Natrajan, CDC Division of Laboratory Systems (DLS)
Biosafety Guidance Update: Aufra C. Araujo, CDC Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
How the Federal Government is Addressing Laboratory Supply Issues: Steven Santos, HHS Testing and Diagnostics Workgroup, and Matthew Hubbard, HHS Testing and Diagnostics Workgroup
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.